Secondary Infections in Patients with COVID-19 Pneumonia Treated with Tocilizumab Compared to Those Not Treated with Tocilizumab: A Retrospective Study at a Tertiary Hospital in Kenya

INTRODUCTION: From the first case of SARS-Co-2 in Wuhan, China, to the virus being declared as a pandemic in March 2020, the world has witnessed morbidity and mortality on a global scale. Scientists have worked at a record pace to deliver a vaccine for the prevention of this deadly disease. Tocilizu...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Reena, Shah, Jasmit, Gohil, Jaimini, Revathi, Gunturu, Surani, Salim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901262/
https://www.ncbi.nlm.nih.gov/pubmed/35264878
http://dx.doi.org/10.2147/IJGM.S356547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901262/
https://www.ncbi.nlm.nih.gov/pubmed/35264878
http://dx.doi.org/10.2147/IJGM.S356547

Ejemplares similares